Headlines

Users Support Indoor Tanning Device Age Restrictions, Stronger Health Warnings, But Not Total Ban

Three-quarters of young adult women who visit indoor tanning salons support stronger restrictions on their use, including minimum age requirements; however, most do not support a total ban.

Bone Marrow vs Bloodstream: Stem Cell Source Influences Transplantation Outcomes

Blood stem cells derived from donor bone marrow resulted in better self-reported psychological well-being, fewer GVHD symptoms, and earlier return to work for the recipients compared with stem cells derived from the donor's bloodstream.

Adolescent Girls With Breast Cancer Family History Have Higher Self-esteem

Adolescent Girls With Breast Cancer Family History Have Higher Self-esteem

Adolescent girls from BRCA1/2 mutation-positive and breast cancer families have high self-esteem but greater breast-cancer specific-distress.

Gemcitabine Plus Cisplatin Prolongs PFS in Nasopharyngeal Cancer

Gemcitabine Plus Cisplatin Prolongs PFS in Nasopharyngeal Cancer

Gemcitabine in combination with cisplatin is associated with a significant improvement in progression-free survival in nasopharyngeal carcinoma.

TKIs Improve Overall Survival in NSCLC Patients With Leptomeningeal Metastases

TKIs Improve Overall Survival in NSCLC Patients With Leptomeningeal Metastases

Longer overall survival was achieved with TKIs targeting EGFR mutations in non-small cell lung cancer (NSCLC) patients.

Risk for Adverse Pulmonary Events Higher in Adult Survivors of Childhood Cancer

Risk for Adverse Pulmonary Events Higher in Adult Survivors of Childhood Cancer

Adult survivors of childhood cancer are at increased risk for late adverse pulmonary events.

Patient Expectations Linked to Clinical Outcome from Endocrine Treatment

Patient Expectations Linked to Clinical Outcome from Endocrine Treatment

Negative patient expectations are associated with an increased risk of adverse events in patients with breast cancer undergoing endocrine therapy.

Daratumumab Plus Len-Dex an Encouraging Combo for Multiple Myeloma

Daratumumab Plus Len-Dex an Encouraging Combo for Multiple Myeloma

Daratumumab plus lenalidomide and dexamethasone resulted in rapid, deep, durable responses in patients with multiple myeloma.

Breast Cancer Tumors Often a Composite of Tumor Types, Enhancing Treatment Resistance

Breast Cancer Tumors Often a Composite of Tumor Types, Enhancing Treatment Resistance

Estrogen receptor (ER)-positive breast cancers are often not a single tumor but a composite of related tumors, referred to as sub-clones.

Coexisting Diabetes Increases Hospitalizations and Lengths of Stay in Solid-Organ Malignancies

Coexisting Diabetes Increases Hospitalizations and Lengths of Stay in Solid-Organ Malignancies

Coexisting diabetes mellitus (DM) is associated with increased risk for hospitalization, multiple hospitalizations, and longer length of hospital stay.

Conference Coverage

Second-Line Regorafenib Improves Overall Survival in Refractory Liver Cancer

The multikinase inhibitor regorafenib significantly improved overall survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase 3 RESORCE trial.

CT-Based Technique for Body Mass Measurements of Patients With Cancer Improves Disease Staging, Therapy Monitoring

A new method of measuring lean body mass accounts for changes in body composition, enabling improved disease staging and monitoring of therapy.

Overall Survival and Progression-Free Survival Are Improved With Ibrutinib for del17p CLL

Ibrutinib treatment for chronic lymphocytic leukemia with the deletion of chromosome 17p (del17p CLL) increases the percentage of patients alive at 30 months over other therapies for del17p CLL.

Premedication With Antiemetic Improves Length of Stay and Readmissions for a Liver Cancer Procedure

Including an antiemetic in the preprocedure medications for patients with liver cancer undergoing drug eluting bead chemoembolization (DEB TACE) can shorten hospital stays and reduce the chance for readmission due to complications.

Imaging Technique Is Predictive of Immunotherapy Response in Non-Small Cell Lung Cancer

Results from phase II trial on the use of FDG-PET to evaluate the efficacy of an immunotherapy drug in the treatment of NSCLC.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs